BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting

Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial OfficerMr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing ...

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.
Le Lézard

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenue for Q4 and full year ...

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...

Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...
European Medical Journal

How Can Hematologist-Oncologists Tackle Invasive Fungal Infections? Expert Insights from Clinical Practice

The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...

Nutrition plays effective role in slowing chronic kidney disease

From protein intake to salt restriction, Dr Fayaz Ahmad Wani, consultant (nephrology), Fortis Escorts Hospital, Amritsar, delves into the need for frequent, simple and practical diet-related ...